Shafeeq S. Ladha
Experienced in Movement Disorders

Dr. Shafeeq S. Ladha

Neuromusculoskeletal Medicine | Neurology
CommonSpirit Health
Barrow Neuromuscular, MS, MDA, Neuro Ophthalmology
240 W Thomas Rd, Ste 400, 
Phoenix, AZ 
Accepting New Patients
Offers Telehealth

Experienced in Movement Disorders
CommonSpirit Health
Barrow Neuromuscular, MS, MDA, Neuro Ophthalmology
240 W Thomas Rd, Ste 400, 
Phoenix, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

My mission, along with the St. Joseph Medical Group, is to focus on innovative clinical care and the pursuit of excellence through scholarly activities. This allows me to provide patients with state-of-the-art patient services and exceptional patient experiences.

Dr. Ladha is rated as an Experienced provider by MediFind in the treatment of Movement Disorders. His top areas of expertise are Pompe Disease, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, and Spinal Muscular Atrophy (SMA).

His clinical research consists of co-authoring 46 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 1 clinical trial in the study of Movement Disorders.

Specialties
Neuromusculoskeletal Medicine
Neurology
Licenses
Psychiatry & Neurology in AZ
Board Certifications
Psychiatry & Neurology (Neurology)
Psychiatry & Neurology (Sub: Neuromuscular Medicine)
Hospital Affiliations
St Josephs Hospital And Medical Center
Chandler Regional Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
MercyCare
  • EPO
  • HMO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Barrow Neuromuscular, MS, MDA, Neuro Ophthalmology
240 W Thomas Rd, Ste 400, Phoenix, AZ 85013
Call: 602-406-6262

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


13 Clinical Trials

A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Other, Biological
Study Drug: Engensis
Study Phase: Phase 2
Autologous T-Cells Expressing A Chimeric Antigen Receptor Directed To B-Cell Maturation Antigen (BCMA) In Patients With Generalized Myasthenia Gravis (MG)
Autologous T-Cells Expressing A Chimeric Antigen Receptor Directed To B-Cell Maturation Antigen (BCMA) In Patients With Generalized Myasthenia Gravis (MG)
Enrollment Status: Active_not_recruiting
Publish Date: May 28, 2025
Intervention Type: Drug
Study Drug: Descartes-08
Study Phase: Phase 2
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
Enrollment Status: Completed
Publish Date: December 12, 2024
A Prospective, Multi-center, Observational Study of the Safety, Tolerability and Effectiveness of SPINRAZA® (Nusinersen) in Adult Patients With Spinal Muscular Atrophy
A Prospective, Multi-center, Observational Study of the Safety, Tolerability and Effectiveness of SPINRAZA® (Nusinersen) in Adult Patients With Spinal Muscular Atrophy
Enrollment Status: Active_not_recruiting
Publish Date: November 20, 2024
Intervention Type: Other, Drug
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
Open Label, Non-randomized Extension Trial to Assess Long Term Safety and Efficacy of Arimoclomol in Subjects With Amyotropic Lateral Sclerosis Who Have Completed the ORARIALS-01 Trial
Open Label, Non-randomized Extension Trial to Assess Long Term Safety and Efficacy of Arimoclomol in Subjects With Amyotropic Lateral Sclerosis Who Have Completed the ORARIALS-01 Trial
Enrollment Status: Terminated
Publish Date: August 24, 2023
Intervention Type: Drug
Study Drug: Arimoclomol
Study Phase: Phase 3
A Phase 3, Randomised, Placebo-Controlled Trial of Arimoclomol in Amyotropic Lateral Sclerosis
A Phase 3, Randomised, Placebo-Controlled Trial of Arimoclomol in Amyotropic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: August 24, 2023
Intervention Type: Drug
Study Phase: Phase 3
Speech Analysis in ALS Patients With and Without Cognitive Abnormalities: Evaluation of Sensitivity and Disease Progression
Speech Analysis in ALS Patients With and Without Cognitive Abnormalities: Evaluation of Sensitivity and Disease Progression
Enrollment Status: Completed
Publish Date: March 09, 2023
Fluid Biomarkers With Deep Phenotyping in Patients With ALS
Fluid Biomarkers With Deep Phenotyping in Patients With ALS
Enrollment Status: Completed
Publish Date: December 16, 2021
A Phase 2 Pharmacodynamic Trial of Ezogabine (Retigabine) on Neuronal Excitability in Amyotrophic Lateral Sclerosis
A Phase 2 Pharmacodynamic Trial of Ezogabine (Retigabine) on Neuronal Excitability in Amyotrophic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: August 28, 2019
Intervention Type: Drug
Study Phase: Phase 2
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Enrollment Status: Completed
Publish Date: July 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
Enrollment Status: Completed
Publish Date: May 07, 2018
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter Study for the Discovery and Validation of ALS Biomarkers
A Multicenter Study for the Discovery and Validation of ALS Biomarkers
Enrollment Status: Completed
Publish Date: May 30, 2017
View 12 Less Clinical Trials

46 Total Publications

Transthyretin abnormalities in amyotrophic lateral sclerosis: High molecular weight species in cerebrospinal fluid and stromal deposits in choroid plexus.
Transthyretin abnormalities in amyotrophic lateral sclerosis: High molecular weight species in cerebrospinal fluid and stromal deposits in choroid plexus.
Journal: Journal of neuropathology and experimental neurology
Published: July 03, 2025
View All 46 Publications
Similar Doctors
Holly A. Shill
Elite in Movement Disorders
Dr. Holly A. Shill
Neurology
Elite in Movement Disorders
Dr. Holly A. Shill
Neurology

Muhammad Ali Parkinson Center

240 West Thomas Road, Suite 301, 
Phoenix, AZ 
 (0.2 miles away)
602-406-6262
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

My mission, along with the Dignity Health Medical Group, is to focus on innovative clinical care and the pursuit of excellence through scholarly activities. This allows me to provide patients with state-of-the-art patient services and exceptional patient experiences. Dr. Shill is rated as an Elite provider by MediFind in the treatment of Movement Disorders. Her top areas of expertise are Parkinson's Disease, Essential Tremor, Movement Disorders, Deep Brain Stimulation, and Tissue Biopsy.

Elite in Movement Disorders
Dr. Charles H. Adler
Neurology
Elite in Movement Disorders
Dr. Charles H. Adler
Neurology
13400 E Shea Blvd, 
Scottsdale, AZ 
 (17.9 miles away)
480-301-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Charles Adler is a Neurologist in Scottsdale, Arizona. Dr. Adler is rated as an Elite provider by MediFind in the treatment of Movement Disorders. His top areas of expertise are Movement Disorders, Parkinson's Disease, Lewy Body Dementia (LBD), Tissue Biopsy, and Deep Brain Stimulation. Dr. Adler is currently accepting new patients.

David Shprecher
Elite in Movement Disorders
Dr. David Shprecher
Neurology
Elite in Movement Disorders
Dr. David Shprecher
Neurology

Banner Sun Health Research Institute

10515 West Santa Fe Drive, 
Sun City, AZ 
 (14.6 miles away)
623-832-6530
Experience:
16+ years
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

In my spare time... I enjoy hiking, swimming, and playing fetch with my Sheltie dog. Dr. Shprecher is rated as a Distinguished provider by MediFind in the treatment of Movement Disorders. His top areas of expertise are Movement Disorders, Parkinson's Disease, Lewy Body Dementia (LBD), and Progressive Supranuclear Palsy.

VIEW MORE MOVEMENT DISORDERS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ladha's expertise for a condition
ConditionClose
  • Elite
  • Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
    Dr. Ladha is
    Elite
    . Learn about Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).
    See more Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) experts
  • Pompe Disease
    Dr. Ladha is
    Elite
    . Learn about Pompe Disease.
    See more Pompe Disease experts
  • Distinguished
  • Myasthenia Gravis
    Dr. Ladha is
    Distinguished
    . Learn about Myasthenia Gravis.
    See more Myasthenia Gravis experts
  • Primary Lateral Sclerosis
    Dr. Ladha is
    Distinguished
    . Learn about Primary Lateral Sclerosis.
    See more Primary Lateral Sclerosis experts
  • Spinal and Bulbar Muscular Atrophy
    Dr. Ladha is
    Distinguished
    . Learn about Spinal and Bulbar Muscular Atrophy.
    See more Spinal and Bulbar Muscular Atrophy experts
  • Spinal Muscular Atrophy (SMA)
    Dr. Ladha is
    Distinguished
    . Learn about Spinal Muscular Atrophy (SMA).
    See more Spinal Muscular Atrophy (SMA) experts
  • Spinal Muscular Atrophy Type 3
    Dr. Ladha is
    Distinguished
    . Learn about Spinal Muscular Atrophy Type 3.
    See more Spinal Muscular Atrophy Type 3 experts
  • Advanced
  • Chronic Inflammatory Demyelinating Polyneuropathy
    Dr. Ladha is
    Advanced
    . Learn about Chronic Inflammatory Demyelinating Polyneuropathy.
    See more Chronic Inflammatory Demyelinating Polyneuropathy experts
  • Cramp-Fasciculation Syndrome
    Dr. Ladha is
    Advanced
    . Learn about Cramp-Fasciculation Syndrome.
    See more Cramp-Fasciculation Syndrome experts
  • Danon Disease
    Dr. Ladha is
    Advanced
    . Learn about Danon Disease.
    See more Danon Disease experts
  • Delta-Sarcoglycanopathy
    Dr. Ladha is
    Advanced
    . Learn about Delta-Sarcoglycanopathy.
    See more Delta-Sarcoglycanopathy experts
  • Dermatomyositis
    Dr. Ladha is
    Advanced
    . Learn about Dermatomyositis.
    See more Dermatomyositis experts
  • Distal Myopathy 2
    Dr. Ladha is
    Advanced
    . Learn about Distal Myopathy 2.
    See more Distal Myopathy 2 experts
View All 17 Advanced Conditions
  • Experienced
  • Andermann Syndrome
    Dr. Ladha is
    Experienced
    . Learn about Andermann Syndrome.
    See more Andermann Syndrome experts
  • Arachnoiditis
    Dr. Ladha is
    Experienced
    . Learn about Arachnoiditis.
    See more Arachnoiditis experts
  • Arteriovenous Malformation
    Dr. Ladha is
    Experienced
    . Learn about Arteriovenous Malformation.
    See more Arteriovenous Malformation experts
  • Astrocytoma
    Dr. Ladha is
    Experienced
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Atypical Teratoid Rhabdoid Tumor (ATRT)
    Dr. Ladha is
    Experienced
    . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
    See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
  • Benign Rolandic Epilepsy
    Dr. Ladha is
    Experienced
    . Learn about Benign Rolandic Epilepsy.
    See more Benign Rolandic Epilepsy experts
View All 62 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.